1) endostatin
内皮抑制素
1.
Fusion Expression and Identification of Angiostatin and Endostatin in E.coli BL21(DE3);
血管抑制素和内皮抑制素在大肠杆菌中的融合表达与鉴定
2.
Relationship between Endostatin and Vascular Cell Adhesion Mo-lecule-1 Expressions on Bone Marrow Stromal Cells in BMT-mice;
骨髓移植小鼠骨髓基质细胞内皮抑制素(endostatin)及血管细胞黏附分子-1(VCAM-1)表达相关性研究
3.
The preparation of endostatin protein and the measurement of its biologic activity;
内皮抑制素蛋白质的制备及生物学活性测定(英文)
2) endostatin
血管内皮抑制素
1.
Pharmacokinetics of recombinant human endostatin in healthy volunteers and patients with advanced solid tumors;
重组人血管内皮抑制素的人体药动学
2.
Progress of a novel antitumour drug-Endostatin;
抗肿瘤新药血管内皮抑制素的研究进展
3.
Anti-Tumor Effect of Recombinant Human Endostatin on the Growth of Mouse Lewis Lung Carcinoma;
重组人血管内皮抑制素对小鼠Lewis肺癌肿瘤抑制作用
3) Endostatin
内皮细胞抑制素
1.
Experimental study on activity of human recombinant adenovirus vector expressing human endostatin in vitro;
重组人内皮细胞抑制素腺病毒载体体外活性作用的研究
4) endostatin
内皮抑素
1.
Inhibitory effect of recombinant adenovirus-mediated mouse endostatin on pulmonary metastasis of osteosarcoma cell line MG-63 in nude mice;
重组腺病毒介导小鼠内皮抑素对荷骨肉瘤MG-63细胞裸鼠肺转移的抑制
2.
Construction and Expression of Prokaryotic Expression Vector pNZ44-ssEndostatin with Secretable Form of Mouse Endostatin;
小鼠分泌型内皮抑素原核表达载体pNZ44-ssEndostatin的构建及表达
3.
Advance in Research of Endostatin and Its Anti-Tumor Application;
内皮抑素研究进展及在抗肿瘤中的应用
5) endostatin-vascular endothelial growth inhibitor
内皮抑素-血管内皮细胞抑制因子
1.
Inhibitory effects of endostatin-vascular endothelial growth inhibitor recombinant adenoviruses on neovascularization;
内皮抑素-血管内皮细胞抑制因子重组腺病毒对新生血管的抑制效应
6) recombinant human Endostatin
重组人血管内皮抑制素
1.
Clinical application of recombinant human endostatin
重组人血管内皮抑制素临床应用进展
2.
The fermentation process of recombinant human Endostatin expression in Escherichia coli BL21 (DE3) was studied.
优化了重组人血管内皮抑制素的E。
3.
In order to instruct reasonable application of the recombinant Human Endostatin ,the development in clinical research of Endostar for malignant tumor were reviewed in this paper,including clinical results,drug adverse reactions and qulity of life.
介绍重组人血管内皮抑制素(恩度)治疗恶性肿瘤的临床研究情况,包括临床疗效、不良反应和生活质量方面的研究进展,为临床合理应用和评价新药提供参考。
补充资料：内皮素受体
内皮素受体
目前对ETR的调节机制了解极少，可能雌激素促其形成，而孕激素有抑制作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条